表紙:PCR市場:qPCR、dPCR、シングルプレックス、マルチプレックス市場:用途別、製品別、場所別:エグゼクティブガイドとコンサルタントガイド(カスタマイズ予測と分析を含む):Covid-19 診断の影響を含めた最新レポート(2021~2025年)
市場調査レポート
商品コード
1028766

PCR市場:qPCR、dPCR、シングルプレックス、マルチプレックス市場:用途別、製品別、場所別:エグゼクティブガイドとコンサルタントガイド(カスタマイズ予測と分析を含む):Covid-19 診断の影響を含めた最新レポート(2021~2025年)

PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025

出版日: | 発行: Howe Sound Research | ページ情報: 英文 384 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
PCR市場:qPCR、dPCR、シングルプレックス、マルチプレックス市場:用途別、製品別、場所別:エグゼクティブガイドとコンサルタントガイド(カスタマイズ予測と分析を含む):Covid-19 診断の影響を含めた最新レポート(2021~2025年)
出版日: 2021年09月20日
発行: Howe Sound Research
ページ情報: 英文 384 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

COVID-19の診断は、PCRを独占的な技術とし、新しいPCRベースの技術の成長に拍車をかけています。PCRは市場でその存在を証明してきました。そして、新世代のPCRであるデジタルPCRは、この成功を継続させるとみられています。パンデミック診断への大きな需要に後押しされて、さらに加速します。新しいレベルの感度は、液体生検やがん検診市場にも影響を与えます。

当レポートでは、PCR市場について調査し、市場の概要とともに、用途別、製品別、場所別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

  • 状況分析
  • エグゼクティブおよびマーケティングスタッフのためのガイド
  • 投資アナリストおよび経営コンサルタントのためのガイド

第2章 イントロダクションと市場の定義

  • PCR技術とは何か
  • PCRおよび症候群検査
  • 市場の定義
    • 市場規模
    • 通貨
  • 調査手法
    • 著者
    • ソース
  • 展望:ヘルスケア、IVD産業、およびCOVID-19パンデミック
    • 世界のヘルスケア支出
    • 診断への支出
    • 診断のための保険の重要な役割

第3章 PCR-PCR技術のガイド

  • コンセプト
    • 方法
  • 用途
    • 特定のDNAの発見
    • DNAの測定
    • 医療および診断用途
  • PCR-長所と短所
  • さまざまな種類のPCR
    • シンプルな変更
    • デジタルPCR
    • 等温PCR

第4章 業界の概要

  • ダイナミックな市場のプレーヤー
    • 学術調査室
    • 診断テスト開発者
    • ゲノム計装サプライヤー
    • 医薬品/試薬サプライヤー
    • 独立検査室
    • 公的国立/地域研究所
    • 病院検査室
    • 開業医向け検査室
    • 監査機関
    • 認証機関

第5章 市場動向

  • 成長促進要因
    • 新しい基準
    • 下降曲線
    • 多重化
    • 症候群診断は止められない
    • 遺伝的ブリザード症候群
  • 成長抑制要因
    • コスト曲線
    • その他の人々
    • 体系的障害
  • 診断技術の開発
    • 計装曲線
    • 診断の役割の変化
    • 診断は病院の外に
    • 混乱が迫る
    • 次の5年間

第6章 PCRの最近の開発

第7章 主要なPCR企業のプロファイル

  • Abacus Diagnostica
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Agilent
  • Akonni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Aus Diagnostics
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioM?rieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid(now Danaher)
  • Credo Diagnostics Biomedical
  • Cue Health
  • Curetis N.V./Curetis GmbH
  • Diagenode Diagnostics
  • Diasorin S.p.A
  • Enzo Life Sciences, Inc
  • Eurofins Scientific
  • Fluidigm Corp
  • Fluxergy
  • Fusion Genomics
  • Genetic Signatures
  • GenMark Dx
  • Hibergene Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexagene
  • LightDeck Diagnostics
  • Luminex Corp
  • Maxim Biomedical
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Millipore Sigma
  • MIODx
  • Mobidiag
  • Nanomix
  • NGeneBio
  • Operon
  • Panagene
  • Perkin Elmer
  • Precipio
  • Primerdesign
  • Promega
  • Prominex
  • Qiagen Gmbh
  • Quantumdx
  • Quidel
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • T2 Biosystems
  • Thermo Fisher Scientific Inc
  • Veramarx
  • Visby Medical
  • XCR Diagnostics

第8章 世界のPCR市場

  • PCR-国別の世界市場概要
    • 表-国別の世界市場
    • チャート-国別の世界市場
  • 用途別の世界市場-概要
    • 表-用途別の世界市場
    • チャート-世界市場-用途別-セグメントの成長
    • チャート-世界市場-用途別-ベース/最終比較
    • チャート-世界市場-用途別-基準年
    • チャート-世界市場-用途別-最終年度
    • チャート-世界市場-用途別-年別のシェア
  • 世界市場-技術別-概要
    • 表-世界市場-技術別
    • チャート-世界市場-技術別-セグメントの成長
    • チャート-世界市場-技術別-ベース/最終比較
    • チャート-世界市場-技術別-基準年
    • チャート-世界市場-技術別-最終年度
    • チャート-世界市場-技術別-年別のシェア
  • 世界市場-製品別-概要
    • 表-世界市場-製品別
    • チャート-世界市場-製品別-セグメントの成長
    • チャート-世界市場-製品別-ベース/最終比較
    • チャート-世界市場-製品別-基準年
    • チャート-世界市場-製品別-最終年度
    • チャート-世界市場-製品別-年別のシェア
  • 世界市場-場所別-概要
    • 表-世界市場-場所別
    • チャート-世界市場-場所別-セグメントの成長
    • チャート-世界市場-場所別-ベース/最終比較
    • チャート-世界市場-場所別-基準年
    • チャート-世界市場-場所別-最終年度
    • チャート-世界市場-場所別-年別のシェア

第9章 世界のPCR市場-用途別

  • PCR臨床マルチプレックス
  • PCRクリニカルシングルプレックス
  • PCR調査
  • PCRシングルC19
  • その他

第10章 世界のPCR市場-技術別

  • qPCR
  • dPCR
  • シングルC19PCR
  • その他

第11章 世界のPCR市場-製品別

  • PCR装置
  • PCR核酸抽出
  • PCR消耗品
  • PCRサービス

第12章 世界のPCR市場-場所別

  • 臨床検査室
  • ポイントオブケア
  • 商用
  • 医薬品
  • その他

第13章 付録

図表

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Five Factors Driving Growth
  • Table 3 Three Factors Limiting Growth
  • Table 4 Market Size by Country
  • Table 5 Global Market by Application
  • Table 6 Global Market by Technology
  • Table 7 Global Market by Product
  • Table 8 Global Market by Place
  • Table 9 PCR Clinical Multiplex by Country
  • Table 10 PCR Clinical Singleplex by Country
  • Table 11 PCR Research by Country
  • Table 12 PCR Single C19 by Country
  • Table 13 PCR Other by Country
  • Table 14 qPCR by Country
  • Table 15 Single C19 PCR by Country
  • Table 16 Other PCR by Country
  • Table 17 PCR Instruments by Country
  • Table 18 PCR Nucleic Acid Extraction by Country
  • Table 19 PCR Consumables by Country
  • Table 20 PCR Services by Country
  • Table 21 PCR Clinical Clinical Laboratory by Country
  • Table 22 PCR Point of Care by Country
  • Table 23 PCR Commercial by Country
  • Table 24 PCR Pharmaceutical by Country
  • Table 25 PCR Other Place by Country
  • Table 26 2021 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Map - Global Health Care Spending Per Capita
  • Figure 2 The Lab Test Pie - Wholesale vs. Retail
  • Figure 3 The PCR Process
  • Figure 4 Creation of Sample Droplets for Digital PCR
  • Figure 5 Comparing Syndromic and Targeted Testing
  • Figure 6 Comparing The New Diagnostics and Traditional Testing
  • Figure 7 Growth rates of PCR Diagnostic Segments
  • Figure 8 Base year Global Market Share Chart
  • Figure 9 PCR Market by Application - Segments Growth
  • Figure 10 PCR Market by Application - Base vs. final
  • Figure 11 PCR Market Base year
  • Figure 12 PCR Market Final Year
  • Figure 13 Application Share by Year
  • Figure 14 PCR Market by Technology - Segments Growth
  • Figure 15 PCR Market by Technology - Base vs. final
  • Figure 16 PCR Market by Technology Base year
  • Figure 17 PCR Market by Technology Final Year
  • Figure 18 Technology Share by Year
  • Figure 19 PCR Market by Product - Segments Growth
  • Figure 20 PCR Market by Product - Base vs. final
  • Figure 21 PCR Market by Product Base year
  • Figure 22 PCR Market by Product Final Year
  • Figure 23 Product Share by Year
  • Figure 24 PCR Market by Place - Segments Growth
  • Figure 25 PCR Market by Place - Base vs. final
  • Figure 26 PCR Market by Place Base year
  • Figure 27 PCR Market by Place Final Year
  • Figure 28 Place Share by Year
  • Figure 29 PCR Clinical Multiplex Testing Growth
  • Figure 30 PCR Clinical Singleplex Testing Growth
  • Figure 31 PCR Research Growth
  • Figure 32 PCR Single C19 Growth
  • Figure 33 PCR Other Growth
  • Figure 34 qPCR Growth
  • Figure 35 dPCR Growth
  • Figure 36 Single C19 PCR Growth
  • Figure 37 Other PCR Growth
  • Figure 38 PCR Instruments Growth
  • Figure 39 PCR Nucleic Acid Extraction Growth
  • Figure 40 PCR Consumables Growth
  • Figure 41 PCR Services Growth
  • Figure 42 PCR Clinical Clinical Laboratory Growth
  • Figure 43 PCR Point of Care Growth
  • Figure 44 PCR Commercial Growth
  • Figure 45 PCR Pharmaceutical Growth
  • Figure 46 PCR Other Place Growth
目次

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine respiratory screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

The report forecasts the market size out to 2025 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What are PCR Technologies?
  • 2.2 PCR and Syndromic Testing
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Authors
    • 2.4.2 Sources
  • 2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
    • 2.5.1 Global Healthcare Spending
    • 2.5.2 Spending on Diagnostics
    • 2.5.3 Important Role of Insurance for Diagnostics

3 PCR - Guide to PCR Technologies

  • 3.1 Concepts
    • 3.1.1 Method
  • 3.2 Applications
    • 3.2.1 Finding Specific DNA
    • 3.2.2 Measuring DNA
    • 3.2.3 Medical and Diagnostic Applications
      • 3.2.3.1 Carrier, prenatal and tissue typing
      • 3.2.3.2 Cancer Diagnosis and Management
      • 3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity
      • 3.2.3.4 Forensic Applications
      • 3.2.3.5 Science and Research
  • 3.3 PCR - Advantages and Disadvantages
  • 3.4 Different Types of PCR
    • 3.4.1 Simple Changes
      • 3.4.1.1 Multiplex-PCR
      • 3.4.1.2 VNTR PCR
      • 3.4.1.3 Asymmetric PCR
      • 3.4.1.4 Long PCR
      • 3.4.1.5 Nested PCR
      • 3.4.1.6 Quantitative PCR
      • 3.4.1.7 Hot-start PCR
      • 3.4.1.8 Touchdown PCR
      • 3.4.1.9 Assembly PCR
      • 3.4.1.10 Colony PCR
      • 3.4.1.11 Suicide PCR
      • 3.4.1.12 Cold PCR
    • 3.4.2 Digital PCR
      • 3.4.2.1 Droplet Digital PCR
      • 3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3 Digital PCR in Use
      • 3.4.2.4 Digital PCR Commercial History
    • 3.4.3 Isothermal PCR

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Genomic Instrumentation Supplier
      • 4.1.3.1 Cell Separation and Viewing Instrumentation Supplier
    • 4.1.4 Pharmaceutical/Reagent Supplier
    • 4.1.5 Independent Testing Lab
    • 4.1.6 Public National/regional lab
    • 4.1.7 Hospital lab
    • 4.1.8 Physician Lab
    • 4.1.9 Audit Body
    • 4.1.10 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 A New Standard
    • 5.1.2 Down the Curve We Go
    • 5.1.3 Multiplexing
    • 5.1.4 Syndromic Diagnostics Looks Unstoppable
    • 5.1.5 The Genetic Blizzard
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve
    • 5.2.2 The Other Guys
    • 5.2.3 Systemic Roadblocks
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Instrumentation Curve
    • 5.3.2 Shifting Role of Diagnostics
    • 5.3.3 Diagnostics Moves Out of the Hospital
    • 5.3.4 Disruption Looms
    • 5.3.5 The Next Five Years

6 PCR Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
  • 6.3 Finnish Firms to Form Point-of-Care Testing Firm
  • 6.4 Visby Medical Scales Up Handheld PCR Test for STIs
  • 6.5 DnaNudge Raises $60M
  • 6.6 Roche Reports Diagnostics Revenue Up 51 Percent
  • 6.7 BforCure Preparing Multiple ID Panels for PoC qPCR Platform
  • 6.8 Enzo Biochem, CLX Health Partner for C19 Testing for Travel
  • 6.9 Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.10 Roche Acquires GenMark
  • 6.11 Handheld qPCR Devices Close to Commercialization
  • 6.12 Nuclein Closes $14M in Funding
  • 6.13 WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.14 Visby Medical to develop rapid Flu-COVID PCR test
  • 6.15 Thermo Fisher to acquire Mesa Biotech
  • 6.16 Scope Fluidics Secures €6.2M Supporting Rapid MDx
  • 6.17 SARS- Testing Demand to Continue 'Through 2022, and Beyond'
  • 6.18 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • 6.19 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
  • 6.20 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
  • 6.21 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform
  • 6.22 Nucleix Targeting US Market With Bladder, Lung Cancer Assays
  • 6.23 DxTerity Gets CE Mark for At-Home Sample Collection Device
  • 6.24 Fetal Cell-Based NIPT by dDigital PCR Demonstrated
  • 6.25 ChromaCode Raises $28M for new High Def PCR Technology
  • 6.26 ddPCR Used for Fast and Low-Cost NIPT Screening
  • 6.27 Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
  • 6.28 Bio-Rad's ddPCR MSI RUO Assay is available
  • 6.29 ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
  • 6.30 Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
  • 6.31 QIAGEN Plans for Next-Generation Digital PCR Systems
  • 6.32 Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • 6.33 New PCR Technology: Transfer-PCR (tPCR) Applications
  • 6.34 NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • 6.35 Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • 6.36 Paragon Genomics, MGI Tech Form Distribution Alliance

7 Profiles of Key PCR Companies

  • 7.1 Abacus Diagnostica
  • 7.2 Abbott Diagnostics
  • 7.3 Accelerate Diagnostics
  • 7.4 Ador Diagnostics
  • 7.5 Agilent
  • 7.6 Akonni Biosystems
  • 7.7 Alveo Technologies
  • 7.8 Applied BioCode
  • 7.9 Aus Diagnostics
  • 7.10 Beckman Coulter Diagnostics
  • 7.11 Becton, Dickinson and Company
  • 7.12 Binx Health
  • 7.13 Biocartis
  • 7.14 bioMérieux Diagnostics
  • 7.15 Bioneer Corporation
  • 7.16 Bio-Rad Laboratories, Inc
  • 7.17 Bosch Healthcare Solutions GmbH
  • 7.18 Bruker
  • 7.19 Caris Molecular Diagnostics
  • 7.20 Cepheid (now Danaher)
  • 7.21 Credo Diagnostics Biomedical
  • 7.22 Cue Health
  • 7.23 Curetis N.V. / Curetis GmbH
  • 7.24 Diagenode Diagnostics
  • 7.25 Diasorin S.p.A
  • 7.26 Enzo Life Sciences, Inc
  • 7.27 Eurofins Scientific
  • 7.28 Fluidigm Corp
  • 7.29 Fluxergy
  • 7.30 Fusion Genomics
  • 7.31 Genetic Signatures
  • 7.32 GenMark Dx
  • 7.33 Hibergene Diagnostics
  • 7.34 Hologic
  • 7.35 Immunexpress
  • 7.36 Inflammatix
  • 7.37 Invetech
  • 7.38 Janssen Diagnostics
  • 7.39 Karius
  • 7.40 Lexagene
  • 7.41 LightDeck Diagnostics
  • 7.42 Luminex Corp
  • 7.43 Maxim Biomedical
  • 7.44 Mbio Diagnostics
  • 7.45 Meridian Bioscience
  • 7.46 Mesa Biotech
  • 7.47 Millipore Sigma
  • 7.48 MIODx
  • 7.49 Mobidiag
  • 7.50 Nanomix
  • 7.51 NGeneBio
  • 7.52 Operon
  • 7.53 Panagene
  • 7.54 Perkin Elmer
  • 7.55 Precipio
  • 7.56 Primerdesign
  • 7.57 Promega
  • 7.58 Prominex
  • 7.59 Qiagen Gmbh
  • 7.60 Quantumdx
  • 7.61 Quidel
  • 7.62 Roche Molecular Diagnostics
  • 7.63 Saw Diagnostics
  • 7.64 Seegene
  • 7.65 Siemens Healthineers
  • 7.66 SkylineDx
  • 7.67 Sona Nanotech
  • 7.68 SpeeDx
  • 7.69 T2 Biosystems
  • 7.70 Thermo Fisher Scientific Inc
  • 7.71 Veramarx
  • 7.72 Visby Medical
  • 7.73 XCR Diagnostics

8 The Global PCR Markets

  • 8.1 PCR - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by Application - Overview
    • 8.2.1 Table - Global Market by Application
    • 8.2.2 Chart - Global Market by Application - Segments Growth
    • 8.2.3 Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4 Chart - Global Market by Application - Base Year
    • 8.2.5 Chart - Global Market by Application - Final Year
    • 8.2.6 Chart - Global Market by Application - Share by Year
  • 8.3 Global Market by Technology - Overview
    • 8.3.1 Table - Global Market by Technology
    • 8.3.2 Chart - Global Market by Technology - Segments Growth
    • 8.3.3 Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4 Chart - Global Market by Technology - Base Year
    • 8.3.5 Chart - Global Market by Technology - Final Year
    • 8.3.6 Chart - Global Market by Technology - Share by Year
  • 8.4 Global Market by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4 Chart - Global Market by Product - Base Year
    • 8.4.5 Chart - Global Market by Product - Final Year
    • 8.4.6 Chart - Global Market by Product - Share by Year
  • 8.5 Global Market by Place - Overview
    • 8.5.1 Table - Global Market by Place
    • 8.5.2 Chart - Global Market by Place - Segments Growth
    • 8.5.3 Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4 Chart - Global Market by Place - Base Year
    • 8.5.5 Chart - Global Market by Place - Final Year
    • 8.5.6 Chart - Global Market by Place - Share by Year

9 Global PCR Markets - By Application

  • 9.1 PCR Clinical Multiplex
    • 9.1.1 Table PCR Clinical Multiplex Testing - by Country
    • 9.1.2 Chart - PCR Clinical Multiplex Testing Growth
  • 9.2 PCR Clinical Singleplex
    • 9.2.1 Table PCR Clinical Singleplex Testing - by Country
    • 9.2.2 Chart - PCR Clinical Singleplex Testing Growth
  • 9.3 PCR Research
    • 9.3.1 Table PCR Research - by Country
    • 9.3.2 Chart - PCR Research Growth
  • 9.4 PCR Single C19
    • 9.4.1 Table PCR Single C19 - by Country
    • 9.4.2 Chart - PCR Single C19 Growth
  • 9.5 PCR Other
    • 9.5.1 Table PCR Other - by Country
    • 9.5.2 Chart - PCR Other Growth

10 Global PCR Markets - By Technology

  • 10.1 qPCR
    • 10.1.1 Table qPCR - by Country
    • 10.1.2 Chart - qPCR Growth
  • 10.2 dPCR
    • 10.2.1 Table dPCR - by Country
    • 10.2.2 Chart - dPCR Growth
  • 10.3 Single C19 PCR
    • 10.3.1 Table Single C19 PCR - by Country
    • 10.3.2 Chart - Single C19 PCR Growth
  • 10.4 Other PCR
    • 10.4.1 Table Other PCR - by Country
    • 10.4.2 Chart - Other PCR Growth

11 Global PCR Markets - By Product

  • 11.1 PCR Instruments
    • 11.1.1 Table PCR Instruments - by Country
    • 11.1.2 Chart - PCR Instruments Growth
  • 11.2 PCR Nucleic Acid Extraction
    • 11.2.1 Table PCR Nucleic Acid Extraction - by Country
    • 11.2.2 Chart - PCR Nucleic Acid Extraction Growth
  • 11.3 PCR Consumables
    • 11.3.1 Table PCR Consumables - by Country
    • 11.3.2 Chart - PCR Consumables Growth
  • 11.4 PCR Services
    • 11.4.1 Table Services - by Country
    • 11.4.2 Chart - PCR Services Growth

12 Global PCR Markets - By Place

  • 12.1 PCR Clinical Laboratory
    • 12.1.1 Table PCR Clinical Clinical Laboratory - by Country
    • 12.1.2 Chart - PCR Clinical Clinical Laboratory Growth
  • 12.2 PCR Point of Care
    • 12.2.1 Table PCR Point of Care - by Country
    • 12.2.2 Chart - PCR Point of Care Growth
  • 12.3 PCR Commercial
    • 12.3.1 Table PCR Commercial - by Country
    • 12.3.2 Chart - PCR Commercial Growth
  • 12.4 PCR Pharmaceutical
    • 12.4.1 Table PCR Pharmaceutical - by Country
    • 12.4.2 Chart - PCR Pharmaceutical Growth
  • 12.5 PCR Other Place
    • 12.5.1 Table PCR Other Place - by Country
    • 12.5.2 Chart - PCR Other Place Growth

13 Appendices

  • 13.1 I. United States Medicare System: 2021 Clinical Laboratory Fees Schedule